Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission

BACKGROUND: Both exclusive enteral nutrition (EEN) and infliximab (IFX) are recommended as induction therapy for pediatric Crohn's disease (CD). Our aim was to compare long-term disease outcomes of patients initially received with either IFX or EEN. METHODS: Medical records of newly diagnosed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yao, Lou, Yue, Yang, Gan, Luo, Youyou, Lou, Jingan, Cheng, Qi, Yu, Jindan, Fang, Youhong, Zhao, Hong, Peng, Kerong, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462978/
https://www.ncbi.nlm.nih.gov/pubmed/36089982
http://dx.doi.org/10.1155/2022/3813915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462978/
https://www.ncbi.nlm.nih.gov/pubmed/36089982
http://dx.doi.org/10.1155/2022/3813915

Ejemplares similares